Article
Developmental aspects of human hepatic drug glucuronidation in young children and adults
1 Feb 2002
Abstract excerpt
BACKGROUND AND AIMS: The liver represents one of the major sites of human glucuronidation. Many therapeutic drugs are substrates for UDP-glucuronosyltransferases (UGT) leading to the formation of usually inactive glucuronides. Hepatic glucuronidation undergoes significant changes during fetal and neonatal development requiring age adapted drug therapy. Regulation of individual UGT genes during hepatic development...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
